ClinicalTrials.Veeva

Menu

Genetic Studies of Early-onset Dementia

Columbia University logo

Columbia University

Status

Enrolling

Conditions

Dementia, Early Onset

Treatments

Other: Medical questionnaire
Other: Neurocognitive testing
Genetic: Blood draw

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT04906863
AAAQ9793
1R01AG064614 (U.S. NIH Grant/Contract)
5U24AG056270-07 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.

Full description

The study population includes individuals affected by Alzheimer's Disease, mild cognitive impairment, other dementias, cognitively healthy individuals without memory problems, or their family members.

Ascertainment is across both males and females, and all race and ethnic groups.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years and older
  • Individuals diagnosed with dementia, their family members and unrelated healthy controls without dementia.

Exclusion criteria

-Individuals with competing diagnosis such as Huntington's disease, traumatic brain injury, drug or alcohol abuse, or schizophrenia, etc., unless family members of a dementia affected individual

Trial design

1,000 participants in 3 patient groups

Mild Cognitive Impairment
Description:
Individuals with mild cognitive impairment that began before age 70
Treatment:
Genetic: Blood draw
Other: Neurocognitive testing
Other: Medical questionnaire
Dementia/Alzheimer's Disease
Description:
Individuals with Alzheimer's Disease or other dementia that began before age 70
Treatment:
Genetic: Blood draw
Other: Neurocognitive testing
Other: Medical questionnaire
Cognitively Healthy
Description:
Cognitively healthy individuals over the age of 30 years
Treatment:
Genetic: Blood draw
Other: Neurocognitive testing
Other: Medical questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Pamela Del Rosario

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems